38 results
8-K
EX-10.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
and the environment (“Environmental Law”), except for violations and liabilities which, individually or in the aggregate, would not have a Material Adverse … or into the environment surrounding any such property of any Hazardous Substances with respect to which the Company or any Subsidiary has knowledge, except as would
424B5
6sc0d 0vjrm8
1 Feb 24
Prospectus supplement for primary offering
4:49pm
8-K
EX-10.1
rukaoaw62w9ofv5q vzo
1 Feb 24
Entry into a Material Definitive Agreement
4:09pm
424B3
73exuke
4 Apr 23
Prospectus supplement
4:57pm
POS AM
oq7bqbb0be0k5jw9
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
8-K
EX-10.1
3mlw 7o6qnti
16 May 22
Entry into a Material Definitive Agreement
9:49pm
424B5
xgppqbe vbv2
16 May 22
Prospectus supplement for primary offering
9:47pm
PRE 14A
68bp78wu5w oj2
21 Apr 22
Preliminary proxy
4:33pm
S-3
w4at9fj5lqy 5om
7 Feb 22
Shelf registration
12:00am